DrugPatentWatch Database Preview
Details for Patent: 10,058,554
Which drugs does patent 10,058,554 protect, and when does it expire?
Patent 10,058,554 protects PERSERIS KIT and is included in one NDA.
This patent has nineteen patent family members in twelve countries.
Summary for Patent: 10,058,554
| Title: | Sustained release small molecule drug formulation |
| Abstract: | An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having C.sub.max to C.sub.min ratio less than 200 and lag time less than 0.2. |
| Inventor(s): | Luk; Andrew S. (Castro Valley, CA), Junnarkar; Gunjan H. (Palo Alto, CA), Chen; Guohua (Sunnyvale, CA) |
| Assignee: | Indivior UK Limited (Slough, Berkshire, GB) |
| Application Number: | 15/422,626 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,058,554
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indivior Inc | PERSERIS KIT | risperidone | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 210655-001 | Jul 27, 2018 | RX | Yes | No | Start Trial | Start Trial | ADMINISTRATION OF RISPERIDONE | Start Trial | ||||
| Indivior Inc | PERSERIS KIT | risperidone | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 210655-002 | Jul 27, 2018 | RX | Yes | Yes | Start Trial | Start Trial | ADMINISTRATION OF RISPERIDONE | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,058,554
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 056554 | Start Trial | |||
| Austria | 551989 | Start Trial | |||
| Australia | 2006299657 | Start Trial | |||
| Canada | 2624088 | Start Trial | |||
| China | 101365423 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
